UAB "Bioineksas" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,181,378 |
| 131,264 |
| 280,795 |
| 240,206 |
| 26,690 |
| 38.11 |
| 20.33 |
| 729,504 |
| 94,054 |
| 198,789 |
| 381,853 |
| 0.24 |
| 0.13 |
| - |
| - |
| 24.01 |
| 283,666 |
| 2024 |
|---|
| 1,356,770 |
| 142,070 |
| 365,704 |
| 312,858 |
| 32,760 |
| 41.64 |
| 23.06 |
| 972,362 |
| 75,490 |
| 97,025 |
| 674,269 |
| 0.44 |
| 0.08 |
| - |
| - |
| 26.95 |
| 365,704 |
| 2025 |
|---|
| 1,222,090 |
| 122,209 |
| -43,974 |
| -43,974 |
| -4,397 |
| 13.09 |
| -3.60 |
| 858,388 |
| 93,715 |
| 34,159 |
| 767,617 |
| 0.55 |
| 0.11 |
| - |
| - |
| -3.72 |
| -45,457 |
| 2025 |
|---|
| 1,222,090 |
| 122,209 |
| -43,974 |
| -43,974 |
| -4,397 |
| 13.09 |
| -3.60 |
| 858,388 |
| 93,715 |
| 34,159 |
| 767,617 |
| 0.55 |
| 0.11 |
| - |
| - |
| -3.72 |
| -45,457 |
Turnover (€)
2025
Turnover (€)
1,222,090 €-10 % *
Sales per employee (€)
122,209 €-14 % *
Profit before tax (€)
-43,974 €-112 % *
Net Profit (€)
-43,974 €-114 % *
Profit per employee (€)
-4,397 €-113 % *
Total profitability (%)
13.09 %-68.56 % *
Net profitability (%)
-3.60 %-115.61 % *
Equity (€)
858,388 €-12 % *
Amounts Payable And Liabilities (€)
93,715 €24 % *
Non-current Assets (€)
34,159 €-65 % *
CurrentAssets (€)
767,617 €14 % *
Working capital requirement
0.55 25.00 % *
Debt-to-equity ratio
0.11 37.50 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-3.72 %-113.80 % *
EBIT (€)
-45,457 €-112 % *
